---
title: "Sangani Hospitals Ltd (SANGANI) — Share Price, Financials & Analysis"
symbol: "SANGANI"
company: "Sangani Hospitals Ltd"
canonical: "https://tapetide.com/stocks/SANGANI"
isin: "INE0OVI01010"
nse_symbol: "SANGANI"
sector: "Healthcare"
industry: "Healthcare Services"
market_cap_cr: 75.08
generated_at: "2026-09-13T19:07:58.459Z"
---

# Sangani Hospitals Ltd (SANGANI)

Canonical page: https://tapetide.com/stocks/SANGANI

## Company

- **NSE Symbol:** SANGANI
- **ISIN:** INE0OVI01010
- **Sector:** Healthcare
- **Industry:** Healthcare Services
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2023-08-17
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** sanganihospitals.com

## About

Incorporated in 2021, Sangani Hospitals is in the business of Hospital, Laboratory, and Pharmacy[1]

## Latest Price

- **Price:** ₹53.9
- **Change:** -0.6 (-1.1%)
- **Open:** ₹52
- **Day High:** ₹53.9
- **Day Low:** ₹52
- **Previous Close:** ₹54.5
- **Volume:** 3000
- **As Of:** 2026-09-11T09:01:51+00:00

## Key Fundamentals

Observed at 2026-09-11T04:42:48.711705Z.

- **Market Cap:** ₹75.08 Cr
- **Classification:** SME
- **P/E (reported):** 21.4
- **Book Value:** ₹29.75
- **Price to Book:** 1.83
- **Dividend Yield:** 0%
- **ROE:** 7.18%
- **ROCE:** 9.42%
- **Debt to Equity:** 0.05
- **Revenue (yearly):** ₹106.96 Cr
- **Net Income:** ₹5.86 Cr
- **EBITDA:** ₹8.09 Cr
- **52-Week High:** ₹77
- **52-Week Low:** ₹37
- **RSI (14):** 57.24

## Tapetide Score

- **Score:** 55 / 100
- **Score date:** 2026-09-04
- **Archetype:** No Dominant Pattern
- **What it means:** The three pillars do not combine into a recognisable pattern. Read them individually rather than looking for one story — the lack of a pattern is itself the finding.
- **Pillar profile:** Quality: Average · Valuation: Fair · Momentum: Falling
- **Percentile:** 70.1 (of 4473 scored stocks)
- **Confidence:** 86%
- **Data coverage:** 71%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 43.67 | 9% |
| growth | 98.9 | 9% |
| momentum | 43.81 | 12% |
| ownership | 50 | 24% |
| quality | 55.71 | 22% |
| valuation | 51.48 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is almost debt free.
- Company's working capital requirements have reduced from 37.9 days to 29.3 days

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 8.36% over last 3 years.
- Company has high debtors of 210 days.

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| cash flow growth | -30.27% | -8.91% | -89.62% |
| ebitda margin growth | -57.75% | -66.89% | -78.2% |
| net income growth | 125.38% | 24% | 432.73% |
| revenue growth | 369.12% | 90% | 91.07% |
| roce | -12.04% | -16.34% | 14.38% |
| roe | -10.81% | 7.91% | -15.53% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 6 | 10 | 8 | 8 | 10 | 11 | 20 | 86 |
| Expenses | 4 | 8 | 6 | 6 | 8 | 10 | 19 | 80 |
| Operating Profit | 1 | 2 | 2 | 1 | 2 | 1 | 1 | 7 |
| OPM % | 24 | 17 | 22 | 17 | 17 | 7 | 7 | 8 |
| Other Income | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
| Profit before tax | 1 | 1 | 2 | 2 | 2 | 1 | 1 | 6 |
| Tax % | 25 | 28 | 39 | 14 | 25 | 24 | 22 | 29 |
| Net Profit | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 3 |
| EPS in Rs | 0.86 | 0.62 | 0.75 | 1.2 | 1.24 | 0.65 | 0.73 | 1.44 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Sales | 4 | 16 | 16 | 21 | 107 |
| Expenses | 3 | 13 | 13 | 19 | 99 |
| Operating Profit | 1 | 3 | 3 | 2 | 8 |
| OPM % | 35 | 20 | 20 | 12 | 8 |
| Other Income | 0 | 0 | 1 | 2 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 1 | 0 | 1 | 1 |
| Profit before tax | 1 | 2 | 4 | 3 | 8 |
| Tax % | 26 | 25 | 26 | 25 | 28 |
| Net Profit | 1 | 2 | 3 | 3 | 4 |
| EPS in Rs | 2.66 | 1.53 | 1.96 | 1.88 | 2.17 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Equity Capital | 4 | 10 | 14 | 14 | 14 |
| Reserves | 1 | 8 | 20 | 22 | 27 |
| Borrowings | 0 | 0 | 0 | 0 | 2 |
| Other Liabilities | 2 | 2 | 2 | 3 | 71 |
| Total Liabilities | 7 | 20 | 35 | 39 | 114 |
| Fixed Assets | 1 | 12 | 13 | 13 | 32 |
| CWIP | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 4 |
| Other Assets | 6 | 8 | 23 | 26 | 77 |
| Total Assets | 7 | 20 | 35 | 39 | 114 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 0 | 3 | 3 | 2 | 5 |
| Cash from Investing Activity | 0 | -12 | -1 | -1 | -10 |
| Cash from Financing Activity | 1 | 11 | 12 | -2 | -2 |
| Net Cash Flow | 1 | 1 | 15 | -1 | -6 |
| Free Cash Flow | 0 | -9 | 2 | 1 | 0 |
| CFO/OP | 16 | 99 | 130 | 124 | 84 |

### Ratios

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Debtor Days | 203 | 55 | 52 | 51 | 210 |
| Inventory Days | 160 | 34 | 51 | 57 | 7 |
| Days Payable | 455 | 46 | 69 | 51 | 265 |
| Cash Conversion Cycle | -91 | 43 | 34 | 56 | -48 |
| Working Capital Days | 119 | 41 | 38 | 46 | 29 |
| ROCE % | — | 18 | 14 | 10 | 17 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Sep 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 72.48% | 73.22% | 73.22% | 73.22% | 73.22% | 73.22% | 73.22% | 74.09% | 74.09% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 24% | 23.41% | 23.63% | 24.02% | 22.15% | 24.3% | 23.65% | 22.67% | 22.5% |
| Others | 3.53% | 3.38% | 3.16% | 2.77% | 4.64% | 2.48% | 3.14% | 3.24% | 3.41% |
| No. of Shareholders | 555 | 457 | 433 | 431 | 467 | 468 | 431 | 440 | 444 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Buy
- **Buy / Neutral / Sell:** 9 / 6 / 4

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 53.99 | Sell |
| EMA (10) | 53.91 | Sell |
| SMA (20) | 53.7 | Buy |
| EMA (20) | 52.71 | Buy |
| SMA (50) | 48.25 | Buy |
| EMA (50) | 50.37 | Buy |
| SMA (100) | 48.51 | Buy |
| EMA (100) | 50.5 | Buy |
| SMA (200) | 55.27 | Sell |
| EMA (200) | 53.33 | Buy |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 55.44 | Neutral |
| MACD (12,26,9) | 1.7 | Sell |
| Stochastic (14,3,3) | 63.76 | Neutral |
| ADX (14) | 18.33 | Neutral |
| Williams %R (14) | -41.61 | Neutral |
| ATR (14) | 2.11 | High Volatility |
| ROC (12) | 3.36 | Buy |
| Stoch RSI (14) | 12.44 | Buy |
| UO (7,14,28) | 61.83 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 8 Jul - July 6, 2026: Sangani Hospitals revised XBRL filing to correct PAT rounding and EPS discrepancies. | [Reply to Clarification- Financial results 8 Jul - July 6, 2026: Sangani Hospitals revised XBRL filing to correct PAT rounding and EPS discrepancies.](https://nsearchives.nseindia.com/corporate/SANGANIHOSPITALS_06072026181721_Financial_Results_Clarification_2.pdf) |
| 8 January 2026 - Certificate under Reg 74(5) for quarter ended Dec 31, 2025: all shares demat; no rematerialisation requests. | [Certificate under SEBI (Depositories and Participants) Regulations, 2018 8 January 2026 - Certificate under Reg 74(5) for quarter ended Dec 31, 2025: all shares demat; no rematerialisation requests.](https://nsearchives.nseindia.com/corporate/SANGANIHOSPITALS_08012026131731_SHL_74_5_.pdf) |
| 31 March 2026 - Acquired 55% of Sadbhavna Hospital for Rs.18.81 crore; became subsidiary on March 31, 2026. | [General Updates 31 March 2026 - Acquired 55% of Sadbhavna Hospital for Rs.18.81 crore; became subsidiary on March 31, 2026.](https://nsearchives.nseindia.com/corporate/SANGANIHOSPITALS_31032026172130_Regulation_30_Acquision.pdf) |
| 30 October 2025 - SEBI PIT compliance certificate for quarter ended Sep 30, 2025; SDD maintained; two events captured; no non-compliance. | [Structural Digital Database 30 October 2025 - SEBI PIT compliance certificate for quarter ended Sep 30, 2025; SDD maintained; two events captured; no non-compliance.](https://nsearchives.nseindia.com/corporate/SANGANIHOSPITALS_30102025123004_SHL_SDD.pdf) |
| 30 October 2025 - Company exempt from filing Regulation 27 corporate governance report for quarter ended 30 Sep 2025. | [Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter 30 October 2025 - Company exempt from filing Regulation 27 corporate governance report for quarter ended 30 Sep 2025.](https://nsearchives.nseindia.com/corporate/SANGANIHOSPITALS_30102025121746_SHL_Non_applicability_of_CG.pdf) |
| 30 May 2026 - Board approved FY26 audited standalone and consolidated results; appointed SMNK & Company as internal auditor for FY27. | [Outcome of Board Meeting 30 May 2026 - Board approved FY26 audited standalone and consolidated results; appointed SMNK & Company as internal auditor for FY27.](https://nsearchives.nseindia.com/corporate/SANGANIHOSPITALS_30052026154359_Outcome.pdf) |
| 30 April 2026 - Sangani Hospitals Limited has informed regarding 'Non-applicability of Regulation 24A of SEBI (Listing Obligations andDisclosure Requirements) Regulations, 2015 regarding Annual Secretarial Compliance Report'. | [Updates 30 April 2026 - Sangani Hospitals Limited has informed regarding 'Non-applicability of Regulation 24A of SEBI (Listing Obligations andDisclosure Requirements) Regulations, 2015 regarding Annual Secretarial Compliance Report'.](https://nsearchives.nseindia.com/corporate/SANGANIHOSPITALS_30042026182535_24a.pdf) |
| 30 April 2026 - Sangani Hospitals Limited has informed regarding 'Large Corporate Non-Applicability'. | [Updates 30 April 2026 - Sangani Hospitals Limited has informed regarding 'Large Corporate Non-Applicability'.](https://nsearchives.nseindia.com/corporate/SANGANIHOSPITALS_30042026182306_large.pdf) |
| 30 April 2026 - Sangani Hospitals Limited has informed about Certificate under SEBI (Depositories and Participants) Regulations, 2018 | [Certificate under SEBI (Depositories and Participants) Regulations, 2018 30 April 2026 - Sangani Hospitals Limited has informed about Certificate under SEBI (Depositories and Participants) Regulations, 2018](https://nsearchives.nseindia.com/corporate/SANGANIHOSPITALS_30042026184240_Sangani_74.pdf) |
| 3 Sep - Sangani Hospitals to hold 5th AGM on September 28, 2026; approve FY26 accounts, director reappointment, auditor appointment. | [Shareholders meeting 3 Sep - Sangani Hospitals to hold 5th AGM on September 28, 2026; approve FY26 accounts, director reappointment, auditor appointment.](https://nsearchives.nseindia.com/corporate/SANGANIHOSPITALS_03092026182146_Intimation_AGM_Notice.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Annual Report 2026 from nse](https://archives.nseindia.com/annual_reports/SME_AR_31348_SANGANI_2025_2026_A_3566138_04092026121536.pdf) |
| from nse | [Annual Report 2025 from nse](https://archives.nseindia.com/annual_reports/SME_AR_28248_SANGANI_2024_2025_A_1706159_03092025123252.pdf) |
| from nse | [Annual Report 2024 from nse](https://archives.nseindia.com/annual_reports/SME_AR_26229_SANGANI_2023_2024_10092024172639.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:07:58.459Z.